Replies to post #24197 on Regen BioPharma Inc (RGBP)

[cvinvestor]

We need the venture capitalists or other big buyers and money coming in at higher than .05/share on the insider deals. Lander has told us that that will end soon. 10-Q shows another $50,000 coming in from friends and family to be filled at most likely .025-.05/share in January. That won't encourage any big money to come in at .12 or higher, but Koos is not concerned like we are because he makes hundreds of thousands/year with 2015 compensation on the 2015 financials at over $1 million to himself.

Quote from "La Mesa Courrier" article:

Financing for the company has come from “a series of private placements,” said Koos. “Up until recently, it’s been friends, family and me.”

I think we have to wait until 2nd Qtr for significant upwared price movement. HemaX Orphan Drug will be a plus and gain greater attention. If RGBP can follow that up with 2nd Qtr news on discovery of small molecule confirmation at NCATS and/or gov funding as a result, then I believe we turn the corner quickly.

Otherwise, as long as this is a Koos and friends benefit party with basically free undervalued shares for his own personal entourage which create massive losses on the Qtrly financials, who will want to put their money into it?